ArticleActa pharmaceutica Sinica. B2021

Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression.

Xiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.